Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03219333 |
|---|---|
| Brief Title: | A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer (EV-201) |
| First Submitted : | July 13, 2017 |
| First Submitted that Met QC Criteria : | July 13, 2017 |
| First Posted : | July 17, 2017 |
| Last Update Submitted that Met QC Criteria : | May 14, 2020 |
| Last Update Posted : | May 15, 2020 |